Abstract
Purpose. To study the signal transduction mechanisms of tamoxifen via the activation of MAPKs, JNK and ERK in order to understand its regulation of gene expression.
Methods. The effects of tamoxifen (TAM) on the activation of serine/ threonine mitogen-activated protein kinase (MAPK, p42/ERK2) and the stress-activated protein kinases (p46 SAPK or c-Jun N-terminal kinase, JNK1) were evaluated using a human cervical epitheloid carcinoma HeLa cell line.
Results. TAM activated both JNK1 and ERK2 activities in a time- and dose-dependent manner in HeLa cells. The activation of JNK1 was enhanced when the cells were pretreated with prooxidant H2O2.
Conclusions. These studies show that TAM activates the signal transduction kinases, JNK1 and ERK2, which may play important roles in the regulation of gene expression by TAM.
Similar content being viewed by others
REFERENCES
J. R. Harris, M. E. Lippman, U. Veronesi, and W. Willett. N. Engl. J. Med. 327:473–480 (1992).
V. C. Jordan. Breast Cancer Res. Treatment 11:197–209 (1988).
M. C. Sunderland and C. K. Osborne. J. Clin. Oncol. 9:1283–1297 (1991).
E. F. Nuwaysir, Y. P. Dragan, C. R. Jefcoate, V. C. Jordan, and H. C. Pitot. Cancer Res. 55:1780–1786 (1995).
E. T. Hellriegel, G. A. Matwyshyn, P. Fei, K. H. Dragnev, R. W. Nims, R. A. Lubet, and A.-N. T. Kong. Biochem. Pharmacol. 52:1561–1568 (1996).
P. Fei, G. A. Matwyshyn, T. H. Rushmore, and A.-N. T. Kong. Pharm. Res. 13:1043–1048 (1996).
E. Pennisi. Science 273:1171 (1996).
V. C. Jordan and C. S. Murphy. Endocr. Rev. 11:578–610 (1990).
P. Webb, G. N. Lopez, R. M. Uht, and P. J. Kushner. Mol. Endocrinol. 9:443–456 (1995).
U. Gundimeda, Z. H. Chen, and R. Gopalakrishna. J. Biol. Chem. 271:13504–13514, 1996.
N. N. Yang, M. Venugopalan, S. Hardikar, and A. Glasebrook. Science 273:1222–1225 (1996).
M. H. Cobb and E. J. Goddsmith. J. Biol. Chem. 270:14843–14846 (1995).
R. Marais, J. Wynne, and R. Treisman. Cell 73:381–393 (1993).
J. M. Kyriakis, P. Banerjee, E. Nikolakaki, T. Dai, E. Rubie, M. Ahmad, J. Avach, and J. R. Woodgett. Nature 369:156–160 (1994).
B. Su, E. Jacinto, M. Hibi, T. Kallunki, M. Karin, and Y. Ben-Neriah. Cell 77:727–736 (1994).
E. Cano, C. A. Hazzalin, and L. C. Mahadevan. Mol. Cell. Biol. 14:7352–7362 (1994).
V. Adler, A. Schaffer, J. Kim, L. Dolan, and Z. Ronai. J. Biol. Chem. 270:26071–26077 (1995).
B. Derijard, M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. Davis. JNK1: Cell 76:1025–1037 (1994).
H. K. Sluss, T. Barrett, B. Derijard, and R. J. Davis. Mol. Cell. Biol. 14:8376–8384 (1994).
Y. R. Chen, C. F. Meyer, and T. H. Tan. J. Biol. Chem. 271:631–634 (1996).
M. Karin. J. Biol. Chem. 270:16483–16486 (1995).
S. Gupta, D. Campbell, Derijard, and R. J. Davis. Science 267:389–393 (1995).
M. Cavigelli, F. Dolfi, F. X. Claret, and M. Karin. EMBO J. 14:5957–5964 (1995).
A.-N. T. Kong, P. Fei, and B. K. Wong. Pharm. Res. 12:309–312 (1995).
R. Yu, J. Jiao, J. Duh, T. Tan, and A.-N. T. Kong. Cancer Res. 56:2954–2959 (1996).
Z. G. Kathryn, Y. Liu, M. Gorospe, Q. Xu, and N. J. Holbrook. J. Biol. Chem. 271:4138–4142 (1996).
F. J. Staal, M. T. Anderson, G. E. J. Staal, L. A. Herzenberg, C. Gitler, and L. A. Herzenbeerg. Proc. Natl. Acad. Sci. USA 91:3619–3622 (1994).
P. Brennan and L. A. J. O'Neill. Biochim. Biophys. Acta. 1260:167–175 (1995).
K. P. Nephew, T. C. Polek, and S. A. Khan. Endocrinol. 137:219–224 (1996).
Rights and permissions
About this article
Cite this article
Duh, JL., Yu, R., Jiao, JJ. et al. Activation of Signal Transduction Kinases by Tamoxifen. Pharm Res 14, 186–189 (1997). https://doi.org/10.1023/A:1012048626963
Issue Date:
DOI: https://doi.org/10.1023/A:1012048626963